{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:09:28Z","timestamp":1773432568049,"version":"3.50.1"},"reference-count":28,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ellevet Sciences","award":["TTU 2315"],"award-info":[{"award-number":["TTU 2315"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>With the increase in popularity of utilizing cannabidiol (CBD) for human ailments, owners are actively interested in the possible utilization of cannabinoid products for their pets. The evaluation of CBD-rich hemp as an anti-anxiolytic, anti-inflammatory, immunomodulator, and anti-epileptic supplement has been assessed in previous studies in dogs, with adverse events such as ataxia or lethargy noted. In this study, the utilization of CBD-rich hemp was assessed at two concentrations to ascertain the impact on behavior as well as the tolerability of the medication given in a typically recommended dose and then twice that dose. Eighteen dogs were utilized in a randomized, double-blinded, placebo-controlled, 3 \u00d7 3 designed study. Each group of six dogs was provided placebo, 2 mg\/kg, and 4 mg\/kg of a cannabidiol\/cannabidiolic acid (CBD\/CBDA)-rich hemp in two-week intervals with one-week washout periods between each treatment period. Throughout the 10-week treatment period, student evaluations were performed, simulating clients\u2019 subjective assessments. Improvements in anxiety-related behavior and adverse events related to lethargy and ataxia were not observed and may indicate that the utilization of CBD-rich hemp products for behavioral changes may require higher dosing to mitigate unwanted behaviors in normal, healthy dogs. Furthermore, serum chemistry and serum cortisol were evaluated after each treatment period showing only a mildly significant increase in serum alkaline phosphatase when dosing at 4 mg\/kg every 12 h, which is consistent with previously reported CBD dosing at these higher concentrations. Adverse events associated with CBD\/CBDA-rich hemp extract given at 2 and 4 mg\/kg every 12 h for two weeks were not reported, suggesting that using CBD-rich hemp in young, healthy dogs was safe during two weeks of treatment.<\/jats:p>","DOI":"10.3390\/ani14131863","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T13:06:40Z","timestamp":1719234400000},"page":"1863","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tolerability of 2 and 4 mg\/kg Dosing Every 12 Hour of a Cannabidiol- and Cannabidiolic Acid-Rich Hemp Extract on Mixed-Breed Dogs Utilized for Teaching in a Closed Colony"],"prefix":"10.3390","volume":"14","author":[{"given":"Trista","family":"Mills","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9625-4886","authenticated-orcid":false,"given":"Stephanie","family":"Myers","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hughes","sequence":"additional","affiliation":[{"name":"Ellevet Sciences, Portland, ME 04106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Wakshlag","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14850, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Kogan, L., Schoenfeld-Tacher, R., Hellyer, P., and Rishniw, M. (2019). US Veterinarians\u2019 Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions. Front. Vet. Sci., 5.","DOI":"10.3389\/fvets.2018.00338"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jsap.13619","article-title":"Assessment of cannabidiol use in pets according to a national survey in the USA","volume":"64","author":"MacQuiddy","year":"2023","journal-title":"J. Small Anim. Pract."},{"key":"ref_3","first-page":"45","article-title":"Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements","volume":"11","author":"Wakshlag","year":"2020","journal-title":"Vet. Med. Res. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gamble, L.J., Boesch, J.M., Frye, C.W., Schwark, W.S., Mann, S., Wolfe, L., Brown, H., Berthelsen, E.S., and Wakshlag, J.J. (2018). Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Front. Vet. Sci., 5.","DOI":"10.3389\/fvets.2018.00165"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/j.pain.0000000000001896","article-title":"A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain","volume":"161","author":"Verrico","year":"2020","journal-title":"Pain"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Brioschi, F.A., Di Cesare, F., and Gioeni, D. (2020). Oral Transmucosal Cannabidiol Oil Formulation as Part of a Multimodal Analgesic Regimen: Effects on Pain Relief and Quality of Life Improvement in Dogs Affected by Spontaneous Osteoarthritis. Animals, 10.","DOI":"10.3390\/ani10091505"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/vde.13077","article-title":"The effect of a mixed cannabidiol and cannabidiolic acid based oil on client-owned dogs with atopic dermatitis","volume":"33","author":"Loewinger","year":"2022","journal-title":"Vet. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garcia, G.A., Kube, S., Carrera-Justiz, S., Tittle, D., and Wakshlag, J.J. (2022). Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.939966"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2460\/javma.254.11.1301","article-title":"Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy","volume":"254","author":"McGrath","year":"2019","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/jvim.16912","article-title":"The efficacy and safety of cannabidiol as adjunct treatment for drug-resistant idiopathic epilepsy in 51 dogs: A double-blinded crossover study","volume":"37","author":"Rozental","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Deabold, K.A., Schwark, W.S., Wolf, L., and Wakshlag, J.J. (2019). Single-dose pharmacokinetics and preliminary safety assessment with use of CBD-rich hemp nutraceutical in healthy dogs and cats. Animals, 9.","DOI":"10.3390\/ani9100832"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/jvim.16949","article-title":"Tolerability of long-term cannabidiol supplementation to healthy adult dogs","volume":"38","author":"Wilson","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bookout, W., Dziwenka, M., Valm, K., and Kovacs-Nolan, J. (2024). Safety study of cannabidiol products in healthy dogs. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1349590"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bradley, S., Young, S., Bakke, A.M., Holcombe, L., Waller, D., Hunt, A., Pinfold, K., Watson, P., and Logan, D.W. (2022). Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.977457"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/bph.14165","article-title":"Species-specific susceptibility to cannabis-induced convulsions","volume":"176","author":"Whalley","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/s41598-021-82439-2","article-title":"Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs","volume":"11","author":"Corsetti","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Morris, E.M., Kitts-Morgan, S.E., Spangler, D.M., McLeod, K.R., Costa, J.H.C., and Harmon, D.L. (2020). The Impact of Feeding Cannabidiol (CBD) Containing Treats on Canine Response to a Noise-Induced Fear Response Test. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.569565"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hunt, A.B.G., Flint, H.E., Logan, D.W., and King, T. (2023). A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1112604"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chicoine, A., Illing, K., Vuong, S., Pinto, K.R., Alcorn, J., and Cosford, K. (2020). Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.583404"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wakshlag, J.J., Schwark, W.S., Deabold, K.A., Talsma, B.N., Cital, S., Lyubimov, A., Iqbal, A., and Zakharov, A. (2020). Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, \u03949-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum after Dosing with Three Oral Forms of Hemp Extract. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.00505"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvp.13403","article-title":"Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein","volume":"47","author":"Court","year":"2024","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2460\/ajvr.21.08.0120","article-title":"Drug-drug interaction between cannabidiol and phenobarbital in healthy dogs","volume":"83","author":"Doran","year":"2021","journal-title":"Am. J. Vet. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40429-020-00326-8","article-title":"Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies","volume":"7","author":"Sholler","year":"2020","journal-title":"Curr. Addict. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"skad414","DOI":"10.1093\/jas\/skad414","article-title":"Daily dosing of cannabidiol (CBD) demonstrates a positive effect on measures of stress in dogs during repeated exposure to car travel","volume":"102","author":"Flint","year":"2024","journal-title":"J. Anim. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2460\/ajvr.22.01.0006","article-title":"Feeding decreases the oral bioavailability of cannabidiol and cannabidiolic acid in hemp oil in New Zealand White rabbits (Oryctolagus cuniculus)","volume":"83","author":"Rooney","year":"2022","journal-title":"Am. J. Vet. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, T., Zakharov, A., Gomez, B., Lyubimov, A., Trottier, N.L., Schwark, W.S., and Wakshlag, J.J. (2022). Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD\/CBDA Rich Hemp Paste. Front. Vet. Sci., 9.","DOI":"10.3389\/fvets.2022.895368"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Johns, T.N., Wakshlag, J.J., Lyubimov, A.V., Zakharov, A., and Burnside, W.M. (2023). Pharmacokinetics of cannabidiol-\/cannabidiolic acid-rich hemp oil in juvenile cynomolgus macaques (Macaca fascicularis). Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1286158"},{"key":"ref_28","first-page":"1","article-title":"Twice-daily oral administration of a cannabidiol and cannabidiolic acid-rich hemp extract was well tolerated in orange-winged Amazon parrots (Amazona amazonica) and has a favorable pharmacokinetic profile","volume":"84","author":"Guzman","year":"2023","journal-title":"Am. J. Vet. Res."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/13\/1863\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:03:43Z","timestamp":1760108623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/13\/1863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":28,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ani14131863"],"URL":"https:\/\/doi.org\/10.3390\/ani14131863","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}